GlassScriptPhysician profile
Jaclyn Schumann
NPI 1184121030
$28,792.12
in general payments reported to CMS, 2019-2025
22 companies · $6,643 in 2025
The $6,643 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.63 · 2020: $579 · 2021: $14K · 2022: $4,507 · 2023: $2,213 · 2024: $1,203 · 2025: $6,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,149 · Travel and Lodging: $3,410 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,149.05 |
| Travel and Lodging | $3,410.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $16,390.12 | 2021-2025 | |
| Stryker Corporation | $6,159.53 | 2021-2025 | Augment Injectable, Variax, Hoffmann |
| Medwest Associates | $1,837.11 | 2020-2023 | |
| Kerecis Limited | $1,042.41 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Paragon 28, INC. | $960.56 | 2021 | |
| Lightbody Medical Technologies INC | $830.20 | 2024-2025 | |
| Organogenesis INC. | $387.37 | 2021-2025 | Puraply Wound Matrix |
| Medline Industries LP | $181.22 | 2021-2025 | |
| Flower Orthopedics Coporation | $167.82 | 2022-2024 | |
| Acera Surgical, INC. | $154.38 | 2022-2024 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $129.33 | 2021 | |
| Crossroads Orthopedics, LLC | $125.00 | 2022 | |
| Depuy Synthes Sales INC. | $80.81 | 2024-2025 | Na, Lcp, N/A |
| Horizon Therapeutics Plc | $80.63 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $57.57 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $46.42 | 2023-2025 | Physio-Stim |
| Fusion Orthopedics USA, LLC | $38.38 | 2024 | |
| Baudax Bio INC. | $35.75 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $27.56 | 2025 | Euflexxa |
| Mimedx Group, INC. | $27.23 | 2024 | |
| Zimmer Biomet Holdings, INC. | $20.59 | 2022 | |
| Paratek Pharmaceuticals, INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Schumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.